GT Biopharma, Inc. - Common Stock (GTBP)

Historical Holders from Q4 2023 to Q3 2025

Symbol
GTBP on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
3,148,458
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
369,208
Holdings value
$217,520
% of all portfolios
0%
Number of holders
20
Number of buys
7
Number of sells
-7
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of GT Biopharma, Inc. - Common Stock (GTBP)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Five Narrow Lane LP 9.99% $552,386 253,388 Five Narrow Lane LP 13 May 2025
CYTOVANCE BIOLOGICS INC 9.8% $478,416 219,457 CYTOVANCE BIOLOGICS INC 30 Sep 2024
BRISTOL INVESTMENT FUND LTD 2.37% $171,405 74,524 Bristol Investment Fund, Ltd. 29 May 2025

Institutional Holders of GT Biopharma, Inc. - Common Stock (GTBP)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 369,208 $217,520 +$21,414 $0.5871 20
2025 Q2 198,676 $711,263 +$381,370 $3.58 21
2025 Q1 99,688 $220,497 -$29,000,935 $2.15 20
2024 Q4 1,244,880 $29,297,553 +$4,192 $3.05 18
2024 Q3 1,246,007 $35,300,829 +$5,339,749 $2.31 15
2024 Q2 1,080,160 $38,124,773 +$37,905,403 $2.83 16
2024 Q1 75,442 $348,558 +$348,261 $4.43 15
2023 Q4 208 $53 +$53 $0.2560 2